MO HCR82 | 2020 | Regular Session
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 10 2020 - 25% progression, died in committee
Action: 2020-05-15 - Referred: Health and Mental Health Policy(H)
Pending: House Health and Mental Health Policy Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 10 2020 - 25% progression, died in committee
Action: 2020-05-15 - Referred: Health and Mental Health Policy(H)
Pending: House Health and Mental Health Policy Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Urges the department of social services and the office of administration to examine the potential cost savings of providing enhanced coverage for biosimilar drugs for participants in Mo HealthNet and the state employee insurance plan.
Title
Urges the department of social services and the office of administration to examine the potential cost savings of providing enhanced coverage for biosimilar drugs for participants in Mo HealthNet and the state employee insurance plan.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2020-05-15 | House | Referred: Health and Mental Health Policy(H) |
| 2020-02-11 | House | Read Second Time (H) |
| 2020-02-10 | House | Introduced and Read First Time (H) |
Missouri State Sources
| Type | Source |
|---|---|
| Summary | https://www.house.mo.gov/Bill.aspx?bill=HCR82&year=2020&code=R |
| Text | https://www.house.mo.gov/billtracking/bills201/hlrbillspdf/5298H.01I.pdf |
